• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于聚类分析和临床决策树分类的新型冠状病毒肺炎患者高效管理策略

Efficient management strategy of COVID-19 patients based on cluster analysis and clinical decision tree classification.

作者信息

Li Zhi, Wang Ling, Huang Lv-Shuai, Zhang Meng, Cai Xianhua, Xu Feng, Wu Fei, Li Honghua, Huang Wencai, Zhou Qunfang, Yao Jing, Liang Yong, Liu Guoliang

机构信息

Department of Orthopedics, General Hospital of Chinese PLA Central Theater Command, Wuhan, 430070, China.

Southern Medical University, Guangzhou, 510515, China.

出版信息

Sci Rep. 2021 May 5;11(1):9626. doi: 10.1038/s41598-021-89187-3.

DOI:10.1038/s41598-021-89187-3
PMID:33953307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8100107/
Abstract

Early classification and risk assessment for COVID-19 patients are critical for improving their terminal prognosis, and preventing the patients deteriorate into severe or critical situation. We performed a retrospective study on 222 COVID-19 patients in Wuhan treated between January 23rd and February 28th, 2020. A decision tree algorithm has been established including multiple factor logistic for cluster analyses that were performed to assess the predictive value of presumptive clinical diagnosis and features including characteristic signs and symptoms of COVID-19 patients. Therapeutic efficacy was evaluated by adopting Kaplan-Meier survival curve analysis and cox risk regression. The 222 patients were then clustered into two groups: cluster I (common type) and cluster II (high-risk type). High-risk cases can be judged from their clinical characteristics, including: age > 50 years, chest CT images with multiple ground glass or wetting shadows, etc. Based on the classification analysis and risk factor analysis, a decision tree algorithm and management flow chart were established, which can help well recognize individuals who needs hospitalization and improve the clinical prognosis of the COVID-19 patients. Our risk factor analysis and management process suggestions are useful for improving the overall clinical prognosis and optimize the utilization of public health resources during treatment of COVID-19 patients.

摘要

对新型冠状病毒肺炎(COVID-19)患者进行早期分类和风险评估对于改善其最终预后以及防止患者病情恶化为重症或危重症至关重要。我们对2020年1月23日至2月28日期间在武汉接受治疗的222例COVID-19患者进行了一项回顾性研究。建立了一种决策树算法,包括用于聚类分析的多因素逻辑回归,以评估推定临床诊断和特征(包括COVID-19患者的特征性体征和症状)的预测价值。采用Kaplan-Meier生存曲线分析和Cox风险回归评估治疗效果。然后将这222例患者分为两组:第一组(普通型)和第二组(高危型)。高危病例可根据其临床特征判断,包括:年龄>50岁、胸部CT图像有多个磨玻璃或实变影等。基于分类分析和危险因素分析,建立了决策树算法和管理流程图,有助于很好地识别需要住院治疗的个体并改善COVID-19患者的临床预后。我们的危险因素分析和管理流程建议对于改善整体临床预后以及在COVID-19患者治疗期间优化公共卫生资源的利用是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/02a0c45ab24b/41598_2021_89187_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/e03d183fe8e9/41598_2021_89187_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/ce7d04b71a10/41598_2021_89187_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/549543cb7e35/41598_2021_89187_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/02a0c45ab24b/41598_2021_89187_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/e03d183fe8e9/41598_2021_89187_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/ce7d04b71a10/41598_2021_89187_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/549543cb7e35/41598_2021_89187_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18da/8100107/02a0c45ab24b/41598_2021_89187_Fig4_HTML.jpg

相似文献

1
Efficient management strategy of COVID-19 patients based on cluster analysis and clinical decision tree classification.基于聚类分析和临床决策树分类的新型冠状病毒肺炎患者高效管理策略
Sci Rep. 2021 May 5;11(1):9626. doi: 10.1038/s41598-021-89187-3.
2
Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.降钙素原水平与 COVID-19 住院患者病情进展和预后的关系。
Int J Med Sci. 2020 Sep 9;17(16):2468-2476. doi: 10.7150/ijms.48396. eCollection 2020.
3
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, China.中药治疗重症 COVID-19 患者的疗效和安全性评估:中国 COVID-19 疫情早期武汉的回顾性病例系列研究。
J Ethnopharmacol. 2021 Sep 15;277:113888. doi: 10.1016/j.jep.2021.113888. Epub 2021 Jan 30.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Clinical features and prognostic factors of patients with COVID-19 in Henan Province, China.中国河南省 COVID-19 患者的临床特征和预后因素。
Hum Cell. 2021 Mar;34(2):419-435. doi: 10.1007/s13577-021-00499-y. Epub 2021 Feb 13.
6
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020.2020 年湖北省武汉市周边地区 COVID-19 的流行病学和临床特征分析。
Pharmacol Res. 2020 Jul;157:104821. doi: 10.1016/j.phrs.2020.104821. Epub 2020 Apr 30.
7
Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.中国湖南普通型 2019 冠状病毒病患者的临床特征和药物治疗方法。
Int J Clin Pharm. 2020 Jun;42(3):837-845. doi: 10.1007/s11096-020-01031-2. Epub 2020 May 14.
8
Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.293 例新冠肺炎住院患者的临床特征及中医治疗特点。
Front Med. 2020 Dec;14(6):760-775. doi: 10.1007/s11684-020-0803-8. Epub 2020 Sep 14.
9
Clinical characteristics and outcomes of 48 patients hospitalized for COVID-19 infection in Wuxi: A retrospective cohort study.无锡 48 例 COVID-19 感染住院患者的临床特征和结局:一项回顾性队列研究。
Medicine (Baltimore). 2021 Feb 5;100(5):e23991. doi: 10.1097/MD.0000000000023991.
10
The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.超重在新型冠状病毒肺炎中的重要性:中国武汉某单中心回顾性分析
Medicine (Baltimore). 2020 Oct 23;99(43):e22766. doi: 10.1097/MD.0000000000022766.

引用本文的文献

1
Perspective from anesthesiologists on the therapy of critically ill patients with COVID-19.麻醉医生对COVID-19危重症患者治疗的观点。
Anesthesiol Perioper Sci. 2023;1(1):5. doi: 10.1007/s44254-023-00009-3. Epub 2023 Mar 10.
2
Clusters of Pregnant Women with Severe Acute Respiratory Syndrome Due to COVID-19: An Unsupervised Learning Approach.COVID-19 导致的严重急性呼吸综合征孕妇聚集性病例:一种无监督学习方法。
Int J Environ Res Public Health. 2022 Oct 19;19(20):13522. doi: 10.3390/ijerph192013522.
3
Combining rank-size and k-means for clustering countries over the COVID-19 new deaths per million.

本文引用的文献

1
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020.2019新型冠状病毒病(COVID-19)疫情的流行病学特征 - 中国,2020年
China CDC Wkly. 2020 Feb 21;2(8):113-122.
2
Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective Study.验证 COVID-19 患者疾病严重程度和结局的预测因子:一项描述性和回顾性研究。
Med. 2020 Dec 18;1(1):128-138.e3. doi: 10.1016/j.medj.2020.05.002. Epub 2020 May 19.
3
Clinical Characteristics, Associated Factors, and Predicting COVID-19 Mortality Risk: A Retrospective Study in Wuhan, China.
结合秩规模法和k均值法对各国每百万人口中因新冠疫情新增死亡人数进行聚类分析。
Chaos Solitons Fractals. 2022 May;158:111975. doi: 10.1016/j.chaos.2022.111975. Epub 2022 Mar 11.
4
The Development and Validation of Simplified Machine Learning Algorithms to Predict Prognosis of Hospitalized Patients With COVID-19: Multicenter, Retrospective Study.中文译文:简化机器学习算法预测 COVID-19 住院患者预后的开发和验证:多中心回顾性研究。
J Med Internet Res. 2022 Jan 21;24(1):e31549. doi: 10.2196/31549.
临床特征、相关因素和预测 COVID-19 死亡率风险:中国武汉的回顾性研究。
Am J Prev Med. 2020 Aug;59(2):168-175. doi: 10.1016/j.amepre.2020.05.002. Epub 2020 May 27.
4
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分,以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
5
From the insight of glucose metabolism disorder: Oxygen therapy and blood glucose monitoring are crucial for quarantined COVID-19 patients.从葡萄糖代谢紊乱的角度来看:氧疗和血糖监测对隔离的新冠肺炎患者至关重要。
Ecotoxicol Environ Saf. 2020 Jul 1;197:110614. doi: 10.1016/j.ecoenv.2020.110614. Epub 2020 Apr 11.
6
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.SARS-CoV-2 与其他呼吸道病原体的合并感染率。
JAMA. 2020 May 26;323(20):2085-2086. doi: 10.1001/jama.2020.6266.
7
False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.2019冠状病毒病中逆转录聚合酶链反应的假阴性及核酸转换延长:而非复发
J Med Virol. 2020 Oct;92(10):1755-1756. doi: 10.1002/jmv.25855. Epub 2020 Jul 11.
8
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.新冠病毒肺炎住院患者基础疾病的患病率:一项系统评价与Meta分析
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
9
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
10
CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19).CT 影像视觉定量评估及新型冠状病毒肺炎(COVID-19)临床分类。
Eur Radiol. 2020 Aug;30(8):4407-4416. doi: 10.1007/s00330-020-06817-6. Epub 2020 Mar 25.